Loading organizations...
§ Private Profile · Centennial, CO, USA
NetRegulus is a technology company.
NetRegulus developed specialized software solutions designed to automate and manage critical regulatory, quality, and clinical processes for organizations within the life sciences sector. Its core offering, NetRegulus v6, served as an enterprise platform for comprehensive complaint handling, corrective and preventive action (CAPA) management, and clinical trial data management. The company provided web-based tools enabling efficient control over complex compliance requirements and operational workflows.
Mark Schaub founded NetRegulus in 1999, identifying a significant market need for streamlined regulatory and quality management within the life sciences industry. His vision centered on empowering these companies with robust software to navigate increasingly intricate compliance landscapes effectively. The company's establishment reflected a foresight into the digital transformation required for stringent industry oversight.
The company primarily served life sciences firms, offering them a robust framework for maintaining compliance and operational excellence. NetRegulus aimed to be the leading partner for organizations striving for rigorous adherence to industry standards, delivering solutions that enhanced data integrity and process control. Its forward-looking vision was to continuously refine its platform to meet the evolving demands of global regulatory environments.
NetRegulus has raised $7.0M across 1 funding round.
NetRegulus has raised $7.0M in total across 1 funding round.
NetRegulus has raised $7.0M in total across 1 funding round.
NetRegulus's investors include Baird Capital, KB Partners.
NetRegulus is a technology company specializing in enterprise software solutions for the life sciences and medical device industries, with its flagship product NetRegulus v6 serving as a leading platform for complaint handling, corrective and preventive action (CAPA) management, and clinical trial data management.[1][2] It targets leading life sciences firms and medical device manufacturers, solving critical compliance and process management challenges in highly regulated environments by delivering 21 CFR Part 11-compliant systems that are flexible, scalable, and tailored to dynamic business needs.[1][2] The software enables organizations to manage evolving requirements through integrated, customizable modules that support adoption, adaptation, or creation of business processes, positioning NetRegulus as a key enabler for operational efficiency in these sectors.[1]
Limited public information is available on NetRegulus's founding details, founders, or early traction, with sources primarily describing it as NetRegulus Inc., a developer of software for the medical device industry.[2][3][4] The company's expertise stems from a team composed largely of former life sciences industry professionals collaborating with software engineers, suggesting an origin rooted in deep domain knowledge to address real-world pain points in regulated industries.[1] It has been associated with technology ecosystems in regions like Finland and New York, potentially indicating early growth or investment activity, though specific timelines or pivotal moments remain undocumented in available data.[3][4]
NetRegulus stands out in the compliance software space through several key strengths:
These features make it particularly appealing for medical device and life sciences firms navigating stringent regulations.[1][2]
NetRegulus rides the trend of digital transformation in regulated industries, where life sciences and medical device companies face mounting pressures from compliance standards like 21 CFR Part 11 amid increasing data volumes from clinical trials and quality management.[1] Its timing aligns with a growing demand for agile, compliant software that supports scalable operations without custom development, fueled by market forces such as stricter FDA oversight and the shift toward integrated enterprise systems.[1] By enabling efficient CAPA, complaint handling, and data management, NetRegulus influences the ecosystem by helping firms accelerate product development and reduce compliance risks, contributing to faster innovation in medtech and biotech.[1][2]
NetRegulus is well-positioned to expand as life sciences firms prioritize compliant, flexible platforms amid rising regulatory complexity and AI-driven process automation. Upcoming trends like enhanced data interoperability and real-time analytics could drive demand for v6 upgrades or new modules, potentially boosting adoption among global medtech players. Its influence may grow through partnerships or acquisitions, solidifying its role in streamlining operations for an industry where compliance is non-negotiable, tying back to its core strength in knowing the business as well as its users do.[1]
NetRegulus has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Series B in March 2003.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2003 | $7M Series B | — | Baird Capital, KB Partners | Announced |